LOGIN
DOWNLOAD
ESPAÑOL
Meta-Analysis
ACE Report #12063
Weak evidence suggests Botulinum Toxin Type A may improve some outcomes in cerebral palsy
How to Cite
OrthoEvidence. Weak evidence suggests Botulinum Toxin Type A may improve some outcomes in cerebral palsy. ACE Report. 2019;8(11):29. Available from: https://myorthoevidence.com/AceReport/Report/12063
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:1
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.
Cochrane Database Syst Rev. 2019. DOI: 10.1002/14651858.CD001408.pub2Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Cerebral palsy is a common childhood condition, with spasticity being one of its most disabling complications. Botulinum Toxin has long been used as first line treatment. The authors performed a Cochrane review of all randomized controlled trials comparing Botulinum Toxin to placebo or an active comparator. Overall, 31 trials randomized 1508 patients. The overall quality of the evidence was low or...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MOREFor Reprints and Permissions, click here
Please Login or Join to leave comments.